Sirna molecules that inhibit rtp801 gene expression and therapeutic uses thereof

• 收藏
• 分享

专利权人:

Silence Therapeutics AG;Quark Pharmaceuticals Inc

发明人:

Feinstein, Elena,Kaufmann, Jörg,Giese, Klaus

申请号：

NO20071240

公开号：

NO342934B1

申请日:

2007.03.07

申请国别(地区):

NO

年份:

2018

代理人:

摘要：

The present invention provides a kind of novel molecular, composition, method and purposes treatment microvascular disorder, eye disease and respiratory state and is based on inhibiting RTP801 genes and/or albumen.Den foreliggende oppfinnelse tilveiebringer hittil ukjente molekyler, sammensetninger, fremgangsmåter og anvendelser for behandling av mikrovaskulære forstyrrelser, øyesykdommer og respiratoriske tilstander med basis i inhibering av RTP801 -genet og/eller proteinet.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/